Global Tumor NGS Genetic Testing Market Growth (Status and Outlook) 2026-2032
The global Tumor NGS Genetic Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
United States market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor NGS Genetic Testing players cover Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Tumor NGS Genetic Testing Industry Forecast? looks at past sales and reviews total world Tumor NGS Genetic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor NGS Genetic Testing sales for 2026 through 2032. With Tumor NGS Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Genetic Testing industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor NGS Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tumor NGS Genetic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Genetic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
United States market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor NGS Genetic Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor NGS Genetic Testing players cover Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Tumor NGS Genetic Testing Industry Forecast? looks at past sales and reviews total world Tumor NGS Genetic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor NGS Genetic Testing sales for 2026 through 2032. With Tumor NGS Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Genetic Testing industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor NGS Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tumor NGS Genetic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Genetic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Liquid Biopsy (Blood Sample)
- Tissue Biopsy
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Foundation Medicine
- Guardant Health
- Illumina
- Thermo Fisher Scientific Inc.
- DIAN DIAGNOSTICS Group Co., Ltd.
- Burning Rock Biotech.
- NovogeneCo.,Ltd.
- Nanjing Shihejiyin Technology, Inc.
- Amoy Diagnostics Co.,Ltd.
- China National Pharmaceutical Group Corporation
- Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- Guangzhou Kingmed Diagnostics Group Co.,Ltd.
- ADICON Clinical Laboratories, Inc.
- Genetron
- Genecast Group Inc.
- BGI Genomics Co.,Ltd.
- Beijing-Geneplus Technology Limited.
- Xiamen SpacegenCo., Ltd.
- Geneis?Beijing?Co.Ltd.
- HaploX
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Genetic Testing Market Size (2021-2032)
2.1.2 Tumor NGS Genetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor NGS Genetic Testing by Country/Region (2021, 2025 & 2032)
2.2 Tumor NGS Genetic Testing Segment by Type
2.2.1 Liquid Biopsy (Blood Sample)
2.2.2 Tissue Biopsy
2.2.3 Tumor NGS Genetic Testing Market Size by Type
2.2.3.1 Tumor NGS Genetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
2.3 Tumor NGS Genetic Testing Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Tumor NGS Genetic Testing Market Size by Application
2.3.4.1 Tumor NGS Genetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
3 TUMOR NGS GENETIC TESTING MARKET SIZE BY PLAYER
3.1 Tumor NGS Genetic Testing Market Size Market Share by Player
3.1.1 Global Tumor NGS Genetic Testing Revenue by Player (2021-2026)
3.1.2 Global Tumor NGS Genetic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Tumor NGS Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS GENETIC TESTING BY REGION
4.1 Tumor NGS Genetic Testing Market Size by Region (2021-2026)
4.2 Global Tumor NGS Genetic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.4 APAC Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.5 Europe Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor NGS Genetic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor NGS Genetic Testing Market Size by Country (2021-2026)
5.2 Americas Tumor NGS Genetic Testing Market Size by Type (2021-2026)
5.3 Americas Tumor NGS Genetic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Genetic Testing Market Size by Region (2021-2026)
6.2 APAC Tumor NGS Genetic Testing Market Size by Type (2021-2026)
6.3 APAC Tumor NGS Genetic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Genetic Testing Market Size by Country (2021-2026)
7.2 Europe Tumor NGS Genetic Testing Market Size by Type (2021-2026)
7.3 Europe Tumor NGS Genetic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Genetic Testing by Region (2021-2026)
8.2 Middle East & Africa Tumor NGS Genetic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS GENETIC TESTING MARKET FORECAST
10.1 Global Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.1.1 Global Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.1.2 Americas Tumor NGS Genetic Testing Forecast
10.1.3 APAC Tumor NGS Genetic Testing Forecast
10.1.4 Europe Tumor NGS Genetic Testing Forecast
10.1.5 Middle East & Africa Tumor NGS Genetic Testing Forecast
10.2 Americas Tumor NGS Genetic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Tumor NGS Genetic Testing Forecast
10.2.2 Canada Market Tumor NGS Genetic Testing Forecast
10.2.3 Mexico Market Tumor NGS Genetic Testing Forecast
10.2.4 Brazil Market Tumor NGS Genetic Testing Forecast
10.3 APAC Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.3.1 China Tumor NGS Genetic Testing Market Forecast
10.3.2 Japan Market Tumor NGS Genetic Testing Forecast
10.3.3 Korea Market Tumor NGS Genetic Testing Forecast
10.3.4 Southeast Asia Market Tumor NGS Genetic Testing Forecast
10.3.5 India Market Tumor NGS Genetic Testing Forecast
10.3.6 Australia Market Tumor NGS Genetic Testing Forecast
10.4 Europe Tumor NGS Genetic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor NGS Genetic Testing Forecast
10.4.2 France Market Tumor NGS Genetic Testing Forecast
10.4.3 UK Market Tumor NGS Genetic Testing Forecast
10.4.4 Italy Market Tumor NGS Genetic Testing Forecast
10.4.5 Russia Market Tumor NGS Genetic Testing Forecast
10.5 Middle East & Africa Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor NGS Genetic Testing Forecast
10.5.2 South Africa Market Tumor NGS Genetic Testing Forecast
10.5.3 Israel Market Tumor NGS Genetic Testing Forecast
10.5.4 Turkey Market Tumor NGS Genetic Testing Forecast
10.6 Global Tumor NGS Genetic Testing Forecast by Type (2027-2032)
10.7 Global Tumor NGS Genetic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor NGS Genetic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Foundation Medicine
11.1.1 Foundation Medicine Company Information
11.1.2 Foundation Medicine Tumor NGS Genetic Testing Product Offered
11.1.3 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Foundation Medicine Main Business Overview
11.1.5 Foundation Medicine Latest Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Information
11.2.2 Guardant Health Tumor NGS Genetic Testing Product Offered
11.2.3 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Guardant Health Main Business Overview
11.2.5 Guardant Health Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Tumor NGS Genetic Testing Product Offered
11.3.3 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product Offered
11.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 DIAN DIAGNOSTICS Group Co., Ltd.
11.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Information
11.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product Offered
11.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Main Business Overview
11.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Latest Developments
11.6 Burning Rock Biotech.
11.6.1 Burning Rock Biotech. Company Information
11.6.2 Burning Rock Biotech. Tumor NGS Genetic Testing Product Offered
11.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Burning Rock Biotech. Main Business Overview
11.6.5 Burning Rock Biotech. Latest Developments
11.7 NovogeneCo.,Ltd.
11.7.1 NovogeneCo.,Ltd. Company Information
11.7.2 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product Offered
11.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 NovogeneCo.,Ltd. Main Business Overview
11.7.5 NovogeneCo.,Ltd. Latest Developments
11.8 Nanjing Shihejiyin Technology, Inc.
11.8.1 Nanjing Shihejiyin Technology, Inc. Company Information
11.8.2 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product Offered
11.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nanjing Shihejiyin Technology, Inc. Main Business Overview
11.8.5 Nanjing Shihejiyin Technology, Inc. Latest Developments
11.9 Amoy Diagnostics Co.,Ltd.
11.9.1 Amoy Diagnostics Co.,Ltd. Company Information
11.9.2 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Amoy Diagnostics Co.,Ltd. Main Business Overview
11.9.5 Amoy Diagnostics Co.,Ltd. Latest Developments
11.10 China National Pharmaceutical Group Corporation
11.10.1 China National Pharmaceutical Group Corporation Company Information
11.10.2 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product Offered
11.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 China National Pharmaceutical Group Corporation Main Business Overview
11.10.5 China National Pharmaceutical Group Corporation Latest Developments
11.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
11.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information
11.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Main Business Overview
11.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Latest Developments
11.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
11.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Information
11.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Main Business Overview
11.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Latest Developments
11.13 ADICON Clinical Laboratories, Inc.
11.13.1 ADICON Clinical Laboratories, Inc. Company Information
11.13.2 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product Offered
11.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 ADICON Clinical Laboratories, Inc. Main Business Overview
11.13.5 ADICON Clinical Laboratories, Inc. Latest Developments
11.14 Genetron
11.14.1 Genetron Company Information
11.14.2 Genetron Tumor NGS Genetic Testing Product Offered
11.14.3 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genetron Main Business Overview
11.14.5 Genetron Latest Developments
11.15 Genecast Group Inc.
11.15.1 Genecast Group Inc. Company Information
11.15.2 Genecast Group Inc. Tumor NGS Genetic Testing Product Offered
11.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genecast Group Inc. Main Business Overview
11.15.5 Genecast Group Inc. Latest Developments
11.16 BGI Genomics Co.,Ltd.
11.16.1 BGI Genomics Co.,Ltd. Company Information
11.16.2 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BGI Genomics Co.,Ltd. Main Business Overview
11.16.5 BGI Genomics Co.,Ltd. Latest Developments
11.17 Beijing-Geneplus Technology Limited.
11.17.1 Beijing-Geneplus Technology Limited. Company Information
11.17.2 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product Offered
11.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Beijing-Geneplus Technology Limited. Main Business Overview
11.17.5 Beijing-Geneplus Technology Limited. Latest Developments
11.18 Xiamen SpacegenCo., Ltd.
11.18.1 Xiamen SpacegenCo., Ltd. Company Information
11.18.2 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product Offered
11.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Xiamen SpacegenCo., Ltd. Main Business Overview
11.18.5 Xiamen SpacegenCo., Ltd. Latest Developments
11.19 Geneis?Beijing?Co.Ltd.
11.19.1 Geneis?Beijing?Co.Ltd. Company Information
11.19.2 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product Offered
11.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Geneis?Beijing?Co.Ltd. Main Business Overview
11.19.5 Geneis?Beijing?Co.Ltd. Latest Developments
11.20 HaploX
11.20.1 HaploX Company Information
11.20.2 HaploX Tumor NGS Genetic Testing Product Offered
11.20.3 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 HaploX Main Business Overview
11.20.5 HaploX Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Genetic Testing Market Size (2021-2032)
2.1.2 Tumor NGS Genetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor NGS Genetic Testing by Country/Region (2021, 2025 & 2032)
2.2 Tumor NGS Genetic Testing Segment by Type
2.2.1 Liquid Biopsy (Blood Sample)
2.2.2 Tissue Biopsy
2.2.3 Tumor NGS Genetic Testing Market Size by Type
2.2.3.1 Tumor NGS Genetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
2.3 Tumor NGS Genetic Testing Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Tumor NGS Genetic Testing Market Size by Application
2.3.4.1 Tumor NGS Genetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
3 TUMOR NGS GENETIC TESTING MARKET SIZE BY PLAYER
3.1 Tumor NGS Genetic Testing Market Size Market Share by Player
3.1.1 Global Tumor NGS Genetic Testing Revenue by Player (2021-2026)
3.1.2 Global Tumor NGS Genetic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Tumor NGS Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS GENETIC TESTING BY REGION
4.1 Tumor NGS Genetic Testing Market Size by Region (2021-2026)
4.2 Global Tumor NGS Genetic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.4 APAC Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.5 Europe Tumor NGS Genetic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor NGS Genetic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor NGS Genetic Testing Market Size by Country (2021-2026)
5.2 Americas Tumor NGS Genetic Testing Market Size by Type (2021-2026)
5.3 Americas Tumor NGS Genetic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Genetic Testing Market Size by Region (2021-2026)
6.2 APAC Tumor NGS Genetic Testing Market Size by Type (2021-2026)
6.3 APAC Tumor NGS Genetic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Genetic Testing Market Size by Country (2021-2026)
7.2 Europe Tumor NGS Genetic Testing Market Size by Type (2021-2026)
7.3 Europe Tumor NGS Genetic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Genetic Testing by Region (2021-2026)
8.2 Middle East & Africa Tumor NGS Genetic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS GENETIC TESTING MARKET FORECAST
10.1 Global Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.1.1 Global Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.1.2 Americas Tumor NGS Genetic Testing Forecast
10.1.3 APAC Tumor NGS Genetic Testing Forecast
10.1.4 Europe Tumor NGS Genetic Testing Forecast
10.1.5 Middle East & Africa Tumor NGS Genetic Testing Forecast
10.2 Americas Tumor NGS Genetic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Tumor NGS Genetic Testing Forecast
10.2.2 Canada Market Tumor NGS Genetic Testing Forecast
10.2.3 Mexico Market Tumor NGS Genetic Testing Forecast
10.2.4 Brazil Market Tumor NGS Genetic Testing Forecast
10.3 APAC Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.3.1 China Tumor NGS Genetic Testing Market Forecast
10.3.2 Japan Market Tumor NGS Genetic Testing Forecast
10.3.3 Korea Market Tumor NGS Genetic Testing Forecast
10.3.4 Southeast Asia Market Tumor NGS Genetic Testing Forecast
10.3.5 India Market Tumor NGS Genetic Testing Forecast
10.3.6 Australia Market Tumor NGS Genetic Testing Forecast
10.4 Europe Tumor NGS Genetic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor NGS Genetic Testing Forecast
10.4.2 France Market Tumor NGS Genetic Testing Forecast
10.4.3 UK Market Tumor NGS Genetic Testing Forecast
10.4.4 Italy Market Tumor NGS Genetic Testing Forecast
10.4.5 Russia Market Tumor NGS Genetic Testing Forecast
10.5 Middle East & Africa Tumor NGS Genetic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor NGS Genetic Testing Forecast
10.5.2 South Africa Market Tumor NGS Genetic Testing Forecast
10.5.3 Israel Market Tumor NGS Genetic Testing Forecast
10.5.4 Turkey Market Tumor NGS Genetic Testing Forecast
10.6 Global Tumor NGS Genetic Testing Forecast by Type (2027-2032)
10.7 Global Tumor NGS Genetic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor NGS Genetic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Foundation Medicine
11.1.1 Foundation Medicine Company Information
11.1.2 Foundation Medicine Tumor NGS Genetic Testing Product Offered
11.1.3 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Foundation Medicine Main Business Overview
11.1.5 Foundation Medicine Latest Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Information
11.2.2 Guardant Health Tumor NGS Genetic Testing Product Offered
11.2.3 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Guardant Health Main Business Overview
11.2.5 Guardant Health Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Tumor NGS Genetic Testing Product Offered
11.3.3 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product Offered
11.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 DIAN DIAGNOSTICS Group Co., Ltd.
11.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Information
11.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product Offered
11.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Main Business Overview
11.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Latest Developments
11.6 Burning Rock Biotech.
11.6.1 Burning Rock Biotech. Company Information
11.6.2 Burning Rock Biotech. Tumor NGS Genetic Testing Product Offered
11.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Burning Rock Biotech. Main Business Overview
11.6.5 Burning Rock Biotech. Latest Developments
11.7 NovogeneCo.,Ltd.
11.7.1 NovogeneCo.,Ltd. Company Information
11.7.2 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product Offered
11.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 NovogeneCo.,Ltd. Main Business Overview
11.7.5 NovogeneCo.,Ltd. Latest Developments
11.8 Nanjing Shihejiyin Technology, Inc.
11.8.1 Nanjing Shihejiyin Technology, Inc. Company Information
11.8.2 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product Offered
11.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nanjing Shihejiyin Technology, Inc. Main Business Overview
11.8.5 Nanjing Shihejiyin Technology, Inc. Latest Developments
11.9 Amoy Diagnostics Co.,Ltd.
11.9.1 Amoy Diagnostics Co.,Ltd. Company Information
11.9.2 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Amoy Diagnostics Co.,Ltd. Main Business Overview
11.9.5 Amoy Diagnostics Co.,Ltd. Latest Developments
11.10 China National Pharmaceutical Group Corporation
11.10.1 China National Pharmaceutical Group Corporation Company Information
11.10.2 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product Offered
11.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 China National Pharmaceutical Group Corporation Main Business Overview
11.10.5 China National Pharmaceutical Group Corporation Latest Developments
11.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
11.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information
11.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Main Business Overview
11.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Latest Developments
11.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
11.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Information
11.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Main Business Overview
11.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Latest Developments
11.13 ADICON Clinical Laboratories, Inc.
11.13.1 ADICON Clinical Laboratories, Inc. Company Information
11.13.2 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product Offered
11.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 ADICON Clinical Laboratories, Inc. Main Business Overview
11.13.5 ADICON Clinical Laboratories, Inc. Latest Developments
11.14 Genetron
11.14.1 Genetron Company Information
11.14.2 Genetron Tumor NGS Genetic Testing Product Offered
11.14.3 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genetron Main Business Overview
11.14.5 Genetron Latest Developments
11.15 Genecast Group Inc.
11.15.1 Genecast Group Inc. Company Information
11.15.2 Genecast Group Inc. Tumor NGS Genetic Testing Product Offered
11.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genecast Group Inc. Main Business Overview
11.15.5 Genecast Group Inc. Latest Developments
11.16 BGI Genomics Co.,Ltd.
11.16.1 BGI Genomics Co.,Ltd. Company Information
11.16.2 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
11.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BGI Genomics Co.,Ltd. Main Business Overview
11.16.5 BGI Genomics Co.,Ltd. Latest Developments
11.17 Beijing-Geneplus Technology Limited.
11.17.1 Beijing-Geneplus Technology Limited. Company Information
11.17.2 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product Offered
11.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Beijing-Geneplus Technology Limited. Main Business Overview
11.17.5 Beijing-Geneplus Technology Limited. Latest Developments
11.18 Xiamen SpacegenCo., Ltd.
11.18.1 Xiamen SpacegenCo., Ltd. Company Information
11.18.2 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product Offered
11.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Xiamen SpacegenCo., Ltd. Main Business Overview
11.18.5 Xiamen SpacegenCo., Ltd. Latest Developments
11.19 Geneis?Beijing?Co.Ltd.
11.19.1 Geneis?Beijing?Co.Ltd. Company Information
11.19.2 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product Offered
11.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Geneis?Beijing?Co.Ltd. Main Business Overview
11.19.5 Geneis?Beijing?Co.Ltd. Latest Developments
11.20 HaploX
11.20.1 HaploX Company Information
11.20.2 HaploX Tumor NGS Genetic Testing Product Offered
11.20.3 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 HaploX Main Business Overview
11.20.5 HaploX Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor NGS Genetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor NGS Genetic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy (Blood Sample)
Table 4. Major Players of Tissue Biopsy
Table 5. Tumor NGS Genetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Table 8. Tumor NGS Genetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor NGS Genetic Testing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor NGS Genetic Testing Revenue Market Share by Player (2021-2026)
Table 13. Tumor NGS Genetic Testing Key Players Head office and Products Offered
Table 14. Tumor NGS Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor NGS Genetic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor NGS Genetic Testing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor NGS Genetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor NGS Genetic Testing Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor NGS Genetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor NGS Genetic Testing Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor NGS Genetic Testing
Table 39. Key Market Challenges & Risks of Tumor NGS Genetic Testing
Table 40. Key Industry Trends of Tumor NGS Genetic Testing
Table 41. Global Tumor NGS Genetic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor NGS Genetic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor NGS Genetic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Foundation Medicine Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 46. Foundation Medicine Tumor NGS Genetic Testing Product Offered
Table 47. Foundation Medicine Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Foundation Medicine Main Business
Table 49. Foundation Medicine Latest Developments
Table 50. Guardant Health Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 51. Guardant Health Tumor NGS Genetic Testing Product Offered
Table 52. Guardant Health Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Guardant Health Main Business
Table 54. Guardant Health Latest Developments
Table 55. Illumina Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 56. Illumina Tumor NGS Genetic Testing Product Offered
Table 57. Illumina Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Illumina Main Business
Table 59. Illumina Latest Developments
Table 60. Thermo Fisher Scientific Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product Offered
Table 62. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc. Main Business
Table 64. Thermo Fisher Scientific Inc. Latest Developments
Table 65. DIAN DIAGNOSTICS Group Co., Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 66. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product Offered
Table 67. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. DIAN DIAGNOSTICS Group Co., Ltd. Main Business
Table 69. DIAN DIAGNOSTICS Group Co., Ltd. Latest Developments
Table 70. Burning Rock Biotech. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 71. Burning Rock Biotech. Tumor NGS Genetic Testing Product Offered
Table 72. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Burning Rock Biotech. Main Business
Table 74. Burning Rock Biotech. Latest Developments
Table 75. NovogeneCo.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 76. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 77. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. NovogeneCo.,Ltd. Main Business
Table 79. NovogeneCo.,Ltd. Latest Developments
Table 80. Nanjing Shihejiyin Technology, Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 81. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product Offered
Table 82. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Nanjing Shihejiyin Technology, Inc. Main Business
Table 84. Nanjing Shihejiyin Technology, Inc. Latest Developments
Table 85. Amoy Diagnostics Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 86. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 87. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Amoy Diagnostics Co.,Ltd. Main Business
Table 89. Amoy Diagnostics Co.,Ltd. Latest Developments
Table 90. China National Pharmaceutical Group Corporation Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 91. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product Offered
Table 92. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. China National Pharmaceutical Group Corporation Main Business
Table 94. China National Pharmaceutical Group Corporation Latest Developments
Table 95. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Main Business
Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Latest Developments
Table 100. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Main Business
Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Latest Developments
Table 105. ADICON Clinical Laboratories, Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 106. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product Offered
Table 107. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. ADICON Clinical Laboratories, Inc. Main Business
Table 109. ADICON Clinical Laboratories, Inc. Latest Developments
Table 110. Genetron Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 111. Genetron Tumor NGS Genetic Testing Product Offered
Table 112. Genetron Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Genetron Main Business
Table 114. Genetron Latest Developments
Table 115. Genecast Group Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 116. Genecast Group Inc. Tumor NGS Genetic Testing Product Offered
Table 117. Genecast Group Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Genecast Group Inc. Main Business
Table 119. Genecast Group Inc. Latest Developments
Table 120. BGI Genomics Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 121. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 122. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. BGI Genomics Co.,Ltd. Main Business
Table 124. BGI Genomics Co.,Ltd. Latest Developments
Table 125. Beijing-Geneplus Technology Limited. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 126. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product Offered
Table 127. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Beijing-Geneplus Technology Limited. Main Business
Table 129. Beijing-Geneplus Technology Limited. Latest Developments
Table 130. Xiamen SpacegenCo., Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 131. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product Offered
Table 132. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Xiamen SpacegenCo., Ltd. Main Business
Table 134. Xiamen SpacegenCo., Ltd. Latest Developments
Table 135. Geneis?Beijing?Co.Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 136. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product Offered
Table 137. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Geneis?Beijing?Co.Ltd. Main Business
Table 139. Geneis?Beijing?Co.Ltd. Latest Developments
Table 140. HaploX Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 141. HaploX Tumor NGS Genetic Testing Product Offered
Table 142. HaploX Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. HaploX Main Business
Table 144. HaploX Latest Developments
Table 1. Tumor NGS Genetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor NGS Genetic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy (Blood Sample)
Table 4. Major Players of Tissue Biopsy
Table 5. Tumor NGS Genetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Table 8. Tumor NGS Genetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor NGS Genetic Testing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor NGS Genetic Testing Revenue Market Share by Player (2021-2026)
Table 13. Tumor NGS Genetic Testing Key Players Head office and Products Offered
Table 14. Tumor NGS Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor NGS Genetic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor NGS Genetic Testing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor NGS Genetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor NGS Genetic Testing Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor NGS Genetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor NGS Genetic Testing Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor NGS Genetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor NGS Genetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor NGS Genetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor NGS Genetic Testing
Table 39. Key Market Challenges & Risks of Tumor NGS Genetic Testing
Table 40. Key Industry Trends of Tumor NGS Genetic Testing
Table 41. Global Tumor NGS Genetic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor NGS Genetic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor NGS Genetic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Foundation Medicine Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 46. Foundation Medicine Tumor NGS Genetic Testing Product Offered
Table 47. Foundation Medicine Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Foundation Medicine Main Business
Table 49. Foundation Medicine Latest Developments
Table 50. Guardant Health Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 51. Guardant Health Tumor NGS Genetic Testing Product Offered
Table 52. Guardant Health Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Guardant Health Main Business
Table 54. Guardant Health Latest Developments
Table 55. Illumina Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 56. Illumina Tumor NGS Genetic Testing Product Offered
Table 57. Illumina Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Illumina Main Business
Table 59. Illumina Latest Developments
Table 60. Thermo Fisher Scientific Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product Offered
Table 62. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc. Main Business
Table 64. Thermo Fisher Scientific Inc. Latest Developments
Table 65. DIAN DIAGNOSTICS Group Co., Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 66. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product Offered
Table 67. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. DIAN DIAGNOSTICS Group Co., Ltd. Main Business
Table 69. DIAN DIAGNOSTICS Group Co., Ltd. Latest Developments
Table 70. Burning Rock Biotech. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 71. Burning Rock Biotech. Tumor NGS Genetic Testing Product Offered
Table 72. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Burning Rock Biotech. Main Business
Table 74. Burning Rock Biotech. Latest Developments
Table 75. NovogeneCo.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 76. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 77. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. NovogeneCo.,Ltd. Main Business
Table 79. NovogeneCo.,Ltd. Latest Developments
Table 80. Nanjing Shihejiyin Technology, Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 81. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product Offered
Table 82. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Nanjing Shihejiyin Technology, Inc. Main Business
Table 84. Nanjing Shihejiyin Technology, Inc. Latest Developments
Table 85. Amoy Diagnostics Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 86. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 87. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Amoy Diagnostics Co.,Ltd. Main Business
Table 89. Amoy Diagnostics Co.,Ltd. Latest Developments
Table 90. China National Pharmaceutical Group Corporation Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 91. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product Offered
Table 92. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. China National Pharmaceutical Group Corporation Main Business
Table 94. China National Pharmaceutical Group Corporation Latest Developments
Table 95. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Main Business
Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Latest Developments
Table 100. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Main Business
Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Latest Developments
Table 105. ADICON Clinical Laboratories, Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 106. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product Offered
Table 107. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. ADICON Clinical Laboratories, Inc. Main Business
Table 109. ADICON Clinical Laboratories, Inc. Latest Developments
Table 110. Genetron Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 111. Genetron Tumor NGS Genetic Testing Product Offered
Table 112. Genetron Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Genetron Main Business
Table 114. Genetron Latest Developments
Table 115. Genecast Group Inc. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 116. Genecast Group Inc. Tumor NGS Genetic Testing Product Offered
Table 117. Genecast Group Inc. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Genecast Group Inc. Main Business
Table 119. Genecast Group Inc. Latest Developments
Table 120. BGI Genomics Co.,Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 121. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product Offered
Table 122. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. BGI Genomics Co.,Ltd. Main Business
Table 124. BGI Genomics Co.,Ltd. Latest Developments
Table 125. Beijing-Geneplus Technology Limited. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 126. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product Offered
Table 127. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Beijing-Geneplus Technology Limited. Main Business
Table 129. Beijing-Geneplus Technology Limited. Latest Developments
Table 130. Xiamen SpacegenCo., Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 131. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product Offered
Table 132. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Xiamen SpacegenCo., Ltd. Main Business
Table 134. Xiamen SpacegenCo., Ltd. Latest Developments
Table 135. Geneis?Beijing?Co.Ltd. Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 136. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product Offered
Table 137. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Geneis?Beijing?Co.Ltd. Main Business
Table 139. Geneis?Beijing?Co.Ltd. Latest Developments
Table 140. HaploX Details, Company Type, Tumor NGS Genetic Testing Area Served and Its Competitors
Table 141. HaploX Tumor NGS Genetic Testing Product Offered
Table 142. HaploX Tumor NGS Genetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. HaploX Main Business
Table 144. HaploX Latest Developments
LIST OF FIGURES
Figure 1. Tumor NGS Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Genetic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor NGS Genetic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor NGS Genetic Testing Sales Market Share by Country/Region (2025)
Figure 8. Tumor NGS Genetic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor NGS Genetic Testing Market Size Market Share by Type in 2025
Figure 10. Tumor NGS Genetic Testing in Companion Diagnostics
Figure 11. Global Tumor NGS Genetic Testing Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 12. Tumor NGS Genetic Testing in Early Cancer Screening
Figure 13. Global Tumor NGS Genetic Testing Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Tumor NGS Genetic Testing in Drug Discovery
Figure 15. Global Tumor NGS Genetic Testing Market: Drug Discovery (2021-2026) & ($ millions)
Figure 16. Global Tumor NGS Genetic Testing Market Size Market Share by Application in 2025
Figure 17. Global Tumor NGS Genetic Testing Revenue Market Share by Player in 2025
Figure 18. Global Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Tumor NGS Genetic Testing Value Market Share by Country in 2025
Figure 24. United States Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tumor NGS Genetic Testing Market Size Market Share by Region in 2025
Figure 29. APAC Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tumor NGS Genetic Testing Market Size Market Share by Country in 2025
Figure 38. Europe Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 61. China Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 65. India Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 68. France Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 1. Tumor NGS Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Genetic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor NGS Genetic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor NGS Genetic Testing Sales Market Share by Country/Region (2025)
Figure 8. Tumor NGS Genetic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor NGS Genetic Testing Market Size Market Share by Type in 2025
Figure 10. Tumor NGS Genetic Testing in Companion Diagnostics
Figure 11. Global Tumor NGS Genetic Testing Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 12. Tumor NGS Genetic Testing in Early Cancer Screening
Figure 13. Global Tumor NGS Genetic Testing Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Tumor NGS Genetic Testing in Drug Discovery
Figure 15. Global Tumor NGS Genetic Testing Market: Drug Discovery (2021-2026) & ($ millions)
Figure 16. Global Tumor NGS Genetic Testing Market Size Market Share by Application in 2025
Figure 17. Global Tumor NGS Genetic Testing Revenue Market Share by Player in 2025
Figure 18. Global Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tumor NGS Genetic Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Tumor NGS Genetic Testing Value Market Share by Country in 2025
Figure 24. United States Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tumor NGS Genetic Testing Market Size Market Share by Region in 2025
Figure 29. APAC Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tumor NGS Genetic Testing Market Size Market Share by Country in 2025
Figure 38. Europe Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tumor NGS Genetic Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tumor NGS Genetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 61. China Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 65. India Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 68. France Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tumor NGS Genetic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tumor NGS Genetic Testing Market Size 2027-2032 ($ millions)
